A pharmaceutical company developing drugs for treatment of dementia
Sep 27, 2022
Sept 27 – 29, 2022 Pharmasum Therapeutics presented at Nordic Life Science Days (NLSD) READ MORE >>
Jul 19, 2022
Pharmasum Therapeutics announces the publication of an article titled “DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes” in the journal Frontiers in Pharmacology. READ MORE >>
May 25, 2022
Pharmasum Therapeutics has entered a collaboration agreement with the University of Oslo READ MORE >>